Bayer AG

BAYN

DE000BAY0017

Pharmaceuticals

Real-time Estimate Tradegate Other stock markets 08:20:51 03/07/2024 pm IST			5-day change	1st Jan Change
26.25 ^EUR	+1.54%		+0.94%	-22.00%

02/07	Cartesian Therapeutics, Inc. Appoints Kemal Malik to its Board of Directors	CI
28/06	Borse Frankfurt-News: Uncertainty ahead of French election (Bond Trading)	DP

Bayer : Third Quarter 2022 Results and News Conference Call

November 08, 2022 at 03:24 pm IST

November

2022

10:01 AM

Europe/Amsterdam

Bayer AG Third Quarter 2022 Results and News Conference Call

Presskit

Newsroom

Sign up for our Newsletter We will keep you informed about the latest news. Sign up

Attachments

Original Link
Original Document
Permalink

Disclaimer

Bayer AG published this content on 08 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 November 2022 09:53:09 UTC.

Latest news about Bayer AG

Cartesian Therapeutics, Inc. Appoints Kemal Malik to its Board of Directors	02/07	CI
Borse Frankfurt-News: Uncertainty ahead of French election (Bond Trading)	28/06	DP
Chemicals collective agreement: Bonus days for union members	27/06	DP
German chemical sector employers, union agree 6.85% pay hike over 20 months	27/06	RE
Chemicals collective bargaining agreement: extra day for trade unionists	27/06	DP
The same old winners	27/06
Bayer's pharmaceuticals division plans to cut further managerial jobs	27/06	RE
Bayer's Pharmaceuticals Unit to Cut More Managerial Jobs Amid Reorganization	27/06	MT
Bayer's pharmaceutical unit plans more managerial cuts in Europe, Asia	27/06	RE
Global markets live: Bayer, FedEx, Nvidia, KKR, Verizon...	26/06
Dpa-AFX Overview: COMPANIES from 26.06.2024 - 15:15	26/06	DP
Anton switch to Dortmund perfect? Voller rows back	26/06	DP
Bayer CEO - Making faster progress with restructuring	26/06	RE
Chemical industry wage partners seek solution before the end of the peace period	26/06	DP
Bayer: patients recruited for phase 2 Parkinson's trial	25/06	CF
Bayer and Solynta Collaborate to Advance True Potato Seed in Smallholder Markets	24/06	CI
Global markets live: Vodafone, Bayer, Apple, Microsoft, Qualcomm...	19/06
Bayer's Crop Science Business Developing AI to Kill Weeds	19/06	MT
Bayer looks to AI to combat herbicide resistance faster	19/06	RE
Transcript : Bayer Aktiengesellschaft - Special Call	19/06
New Bayer short corn variety stands up to high winds, but not over 100 mph	19/06	RE
South Africa finds high prices, lack of competition in its fresh produce market	18/06	RE
Economics Minister Habeck travels to China without prominent company representatives	18/06	RE
Alvotech Enters Commercialization Deal for Eylea Biosimilars with Advanz Pharma	18/06	MT
Nationwide actions - Trade union increases pressure in chemical industry collective bargaining round	18/06	DP

Chart Bayer AG

Duration

Period

More charts

Company Profile

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).

Sector

Pharmaceuticals

Calendar

06/08/2024 - Q2 2024 Earnings Release

Related indices

Euro STOXX 50 Index , STOXX EUROPE 600 (EUR) , DAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

BAYER : As soft as anticipated

May 14, 2024 at 11:42 pm IST

Bayer AG: Not out of the woods yet

March 06, 2024 at 09:16 pm IST

More Strategies

Ratings for Bayer AG

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

25.86 EUR

Average target price

36.18 EUR

Spread / Average Target

+39.94%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BAYER AG	-22.00%	27.27B
ELI LILLY AND COMPANY	+55.42%	816B
NOVO NORDISK A/S	+39.59%	634B
JOHNSON & JOHNSON	-7.42%	351B
MERCK & CO., INC.	+15.80%	323B
ABBVIE INC.	+7.00%	293B
ASTRAZENECA PLC	+13.47%	238B
ROCHE HOLDING AG	+0.74%	222B
NOVARTIS AG	+13.36%	218B
AMGEN INC.	+8.01%	167B

Other Pharmaceuticals

Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Bayer : Third Quarter 2022 Results and News Conference Call

EPS Revisions